Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2013
05/15/2013CN101744285B Method for preparing emulsified and gelatinized functional fatty acid carrier
05/15/2013CN101735205B Crystalline form V of azimilide dihydrochloride, preparation method and application thereof
05/15/2013CN101486713B Furo[2,3-h] chromene compound and use for preventing platelet aggregation
05/15/2013CN101347503B Determining method of salvia root medicinal materials fat soluble component extract content
05/15/2013CN101171927B Choline-silicic acid complex with osmolytes and divalent trace elements
05/14/2013US8440697 Treatment of heart failure
05/14/2013US8440682 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
05/14/2013US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes
05/14/2013US8440644 Compounds as receptor modulators with therapeutic utility
05/14/2013US8440619 Utilization of hypertension/hypercardia-preventing effect of D-allose
05/14/2013US8440615 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase
05/14/2013CA2716369C Phenoxypropylamine compounds
05/14/2013CA2589237C (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4­homopiperazine hydrochloride dihydrate
05/14/2013CA2562287C Sustained-release oral molsidomine composition for treating atherosclerosis
05/14/2013CA2560927C Insulin resistance-improving agent
05/14/2013CA2539193C New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics
05/14/2013CA2497572C Akt inhibitors, pharmaceutical compositions, and uses thereof
05/14/2013CA2461916C Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
05/14/2013CA2453937C Antigenic polypeptides
05/14/2013CA2441562C Short bioactive peptides and methods for their use
05/14/2013CA2435562C Carotenoids as anti-hypertension agents
05/14/2013CA2389487C Process for the production of a reversibly inactive acidified plasmin composition
05/10/2013WO2013067425A1 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
05/10/2013WO2013067260A1 Bicyclic piperazine compounds
05/10/2013WO2013067248A1 Benzoxazines as modulators of ion channels
05/10/2013WO2013067163A1 Neprilysin inhibitors
05/10/2013WO2013066869A1 Piperidinyl-substituted lactams as gpr119 modulators
05/10/2013WO2013065712A1 Diazaspirourea derivative and pharmaceutical use thereof
05/10/2013WO2013064672A2 Oxazaphosphorines dosed one time for treating diseases
05/10/2013WO2013064508A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof
05/10/2013WO2013064307A1 Ivabradine hydrochloride form iv
05/10/2013WO2013064031A1 N-benzylaniline derivative and uses thereof
05/10/2013WO2013064029A1 Benzoylurea derivative with anticancer activity and preparation method and use thereof
05/10/2013WO2013063889A1 Use of multiflora glycoside in preparing anti-hypoxic drug
05/10/2013WO2013037889A3 Vaccine
05/10/2013WO2013032231A3 Pharmaceutical anti-angiogenic composition including a microrna-382 inhibitor
05/10/2013WO2013032230A3 Pharmaceutical angiogenic composition including a microrna-382 activator
05/10/2013WO2013008164A3 Method of treating atherosclerosis in high triglyceride subjects
05/10/2013WO2012155295A8 Industrial production method for producing antihypertensive bioactive peptide
05/10/2013WO2012124311A8 Novel phenylpyridine derivative and drug containing same
05/10/2013CA2854549A1 Ivabradine hydrochloride form iv
05/10/2013CA2854134A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof
05/10/2013CA2853282A1 Nicotinic receptor non-competitive modulators
05/10/2013CA2852964A1 Bicyclic piperazine compounds
05/10/2013CA2852490A1 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
05/10/2013CA2850953A1 Neprilysin inhibitors
05/09/2013US20130116316 Solid Pharmaceutical Compositions Containing Benzofuran Derivatives
05/09/2013US20130116290 Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in Mammals
05/09/2013US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
05/09/2013US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
05/09/2013US20130115319 Herbal composition for lowering likelihood of stroke and methods for healing stroke patients
05/09/2013US20130115288 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone
05/09/2013US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/09/2013US20130115221 HIFa prolyl hydroxylation assay
05/08/2013EP2589601A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof
05/08/2013EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
05/08/2013EP2589594A1 Ivabradine hydrochloride Form IV
05/08/2013EP2589593A1 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[(8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
05/08/2013EP2589588A1 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
05/08/2013EP2589382A1 Pharmaceutical composition comprising levocarnitine and dobesilate
05/08/2013EP2588480A2 3,4-DIHYDROPYRROLO[1,2-A]PYRAZINE-2,8(1H)-DICARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF& xA;
05/08/2013EP2588475A1 Apoptosis signal-regulating kinase inhibitors
05/08/2013EP2588454A1 Substituted dicyanopyridines and use thereof
05/08/2013EP2588197A1 Fused heterocyclic compounds as ion channel modulators
05/08/2013EP2588196A2 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
05/08/2013EP2588125A2 Functional vascularization with biocompatible polysaccharide-based hydrogels
05/08/2013EP2588122A2 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function
05/08/2013EP2588113A1 A reconstituted high density lipoprotein formulation and production method thereof
05/08/2013EP2588111A1 Statin therapy monitored by galectin- 3 measurement
05/08/2013EP2588103A1 A combination of atorvastatin and aspirin to be used in the treatment of cardiovascular diseases
05/08/2013CN202920641U Xiangdan injection production system
05/08/2013CN202920640U Panax notoginseng saponins injection production system
05/08/2013CN103097518A Method for manufacturing multilayered cell sheet, multilayered cell sheet having vascular network obtained thereby, method of use thereof
05/08/2013CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
05/08/2013CN103097387A Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
05/08/2013CN103097385A Ip receptor agonist heterocyclic compounds
05/08/2013CN103097381A 1, 8-naphthyridines as kinase inhibitors
05/08/2013CN103097380A Inhibitor of casein kinase 1[delta] and casein kinase 1[epsilon]
05/08/2013CN103097379A Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them
05/08/2013CN103097374A Metalloenzyme inhibitor compounds
05/08/2013CN103097365A 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (S1P) receptors
05/08/2013CN103097361A 1-(aryl methyl)-quinazoline-2,4-dione as parp inhibitor and its application
05/08/2013CN103096977A Fused heterocyclic compounds as ion channel modulators
05/08/2013CN103096903A The therapeutic use of tetrathiomolybdate
05/08/2013CN103087153A New neovessel inhibition small peptides and applications thereof
05/08/2013CN103087133A Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
05/08/2013CN103087120A Preparation method and application of monosialotetrahexosylganglioside
05/08/2013CN103087078A Thienopyridine and furopyridine kinase inhibitors
05/08/2013CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition
05/08/2013CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith
05/08/2013CN103087026A Crystal form D of 7-hydroxyl isoflavone, preparation method of crystal form D and medicine composition and use of crystal form D
05/08/2013CN103086981A New compounds
05/08/2013CN103086980A Pyrimidine compound for efficiently promoting stem cell proliferation and use thereof
05/08/2013CN103086936A Aryl compounds as PPAR ligands and their use
05/08/2013CN103086926A Preparation method for leonurine and derivatives thereof
05/08/2013CN103086925A Benzoyl urea derivatives having anticancer activity and their preparation method and use
05/08/2013CN103086908A N-benzylaniline derivatives and application thereof
05/08/2013CN103086862A Hydroxydecyl quinone derivative for treating or preventing nerve diseases
05/08/2013CN103086861A Hydroxydecyl benzoquinone derivative and application thereof
05/08/2013CN103083683A Breviscapine phosphatide compound, and preparation method and application thereof
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 1595